Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma

Aniekan Okon, Jingjing Han, Surendra Dawadi, Christos Demosthenous, Courtney Aldrich, Mamta Gupta, Carston R Wagner

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The cellular delivery of nucleotides through various pronucleotide strategies has expanded the utility of nucleosides as a therapeutic class. Although highly successful, the highly popular ProTide system relies on a four-step enzymatic and chemical process to liberate the corresponding monophosphate. To broaden the scope and reduce the number of steps required for monophosphate release, we have developed a strategy that depends on initial chemical activation by a sulfur atom of a methylthioalkyl protecting group, followed by enzymatic hydrolysis of the resulting phosphoramidate monoester. We have employed this ProTide strategy for intracellular delivery of a nucleotide antagonist of eIF4E in mantle cell lymphoma (MCL) cells. Furthermore, we demonstrated that chemical inhibition of cap-dependent translation results in suppression of c-Myc expression, increased p27 expression, and enhanced chemosensitization to doxorubicin, dexamethasone, and ibrutinib. In addition, the new ProTide strategy was shown to enhance oral bioavailability of the corresponding monoester phosphoramidate.

Original languageEnglish (US)
Pages (from-to)8131-8144
Number of pages14
JournalJournal of Medicinal Chemistry
Volume60
Issue number19
DOIs
StatePublished - Oct 12 2017

Fingerprint

Mantle-Cell Lymphoma
Nucleotides
Chemical Phenomena
Nucleosides
Sulfur
Doxorubicin
Dexamethasone
Biological Availability
Hydrolysis
phosphoramidic acid
Therapeutics
PCI 32765

Cite this

Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma. / Okon, Aniekan; Han, Jingjing; Dawadi, Surendra; Demosthenous, Christos; Aldrich, Courtney; Gupta, Mamta; Wagner, Carston R.

In: Journal of Medicinal Chemistry, Vol. 60, No. 19, 12.10.2017, p. 8131-8144.

Research output: Contribution to journalArticle

Okon, Aniekan ; Han, Jingjing ; Dawadi, Surendra ; Demosthenous, Christos ; Aldrich, Courtney ; Gupta, Mamta ; Wagner, Carston R. / Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma. In: Journal of Medicinal Chemistry. 2017 ; Vol. 60, No. 19. pp. 8131-8144.
@article{5c67d8b55d254926b4879fd835b008f5,
title = "Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma",
abstract = "The cellular delivery of nucleotides through various pronucleotide strategies has expanded the utility of nucleosides as a therapeutic class. Although highly successful, the highly popular ProTide system relies on a four-step enzymatic and chemical process to liberate the corresponding monophosphate. To broaden the scope and reduce the number of steps required for monophosphate release, we have developed a strategy that depends on initial chemical activation by a sulfur atom of a methylthioalkyl protecting group, followed by enzymatic hydrolysis of the resulting phosphoramidate monoester. We have employed this ProTide strategy for intracellular delivery of a nucleotide antagonist of eIF4E in mantle cell lymphoma (MCL) cells. Furthermore, we demonstrated that chemical inhibition of cap-dependent translation results in suppression of c-Myc expression, increased p27 expression, and enhanced chemosensitization to doxorubicin, dexamethasone, and ibrutinib. In addition, the new ProTide strategy was shown to enhance oral bioavailability of the corresponding monoester phosphoramidate.",
author = "Aniekan Okon and Jingjing Han and Surendra Dawadi and Christos Demosthenous and Courtney Aldrich and Mamta Gupta and Wagner, {Carston R}",
year = "2017",
month = "10",
day = "12",
doi = "10.1021/acs.jmedchem.7b00916",
language = "English (US)",
volume = "60",
pages = "8131--8144",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "19",

}

TY - JOUR

T1 - Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma

AU - Okon, Aniekan

AU - Han, Jingjing

AU - Dawadi, Surendra

AU - Demosthenous, Christos

AU - Aldrich, Courtney

AU - Gupta, Mamta

AU - Wagner, Carston R

PY - 2017/10/12

Y1 - 2017/10/12

N2 - The cellular delivery of nucleotides through various pronucleotide strategies has expanded the utility of nucleosides as a therapeutic class. Although highly successful, the highly popular ProTide system relies on a four-step enzymatic and chemical process to liberate the corresponding monophosphate. To broaden the scope and reduce the number of steps required for monophosphate release, we have developed a strategy that depends on initial chemical activation by a sulfur atom of a methylthioalkyl protecting group, followed by enzymatic hydrolysis of the resulting phosphoramidate monoester. We have employed this ProTide strategy for intracellular delivery of a nucleotide antagonist of eIF4E in mantle cell lymphoma (MCL) cells. Furthermore, we demonstrated that chemical inhibition of cap-dependent translation results in suppression of c-Myc expression, increased p27 expression, and enhanced chemosensitization to doxorubicin, dexamethasone, and ibrutinib. In addition, the new ProTide strategy was shown to enhance oral bioavailability of the corresponding monoester phosphoramidate.

AB - The cellular delivery of nucleotides through various pronucleotide strategies has expanded the utility of nucleosides as a therapeutic class. Although highly successful, the highly popular ProTide system relies on a four-step enzymatic and chemical process to liberate the corresponding monophosphate. To broaden the scope and reduce the number of steps required for monophosphate release, we have developed a strategy that depends on initial chemical activation by a sulfur atom of a methylthioalkyl protecting group, followed by enzymatic hydrolysis of the resulting phosphoramidate monoester. We have employed this ProTide strategy for intracellular delivery of a nucleotide antagonist of eIF4E in mantle cell lymphoma (MCL) cells. Furthermore, we demonstrated that chemical inhibition of cap-dependent translation results in suppression of c-Myc expression, increased p27 expression, and enhanced chemosensitization to doxorubicin, dexamethasone, and ibrutinib. In addition, the new ProTide strategy was shown to enhance oral bioavailability of the corresponding monoester phosphoramidate.

UR - http://www.scopus.com/inward/record.url?scp=85031311527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031311527&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.7b00916

DO - 10.1021/acs.jmedchem.7b00916

M3 - Article

VL - 60

SP - 8131

EP - 8144

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 19

ER -